Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6101–6150 of 35164
Pursuant to the Merger Agreement, effective as of the Effective Time, each of Michael H. Carrel, Raymond W. Cohen, David M. Demski, Jane E. Kiernan, Esteban López, M.D., Robert E. McNamara, and Nancy L. Snyderman, M.D., FACS, comprising all of the members of the Company’s board of directors, ceased serving as a member of the Company’s board of directors and each committee thereof.
elected Dominick Schiano to the Board to fill the vacancy created by an increase in the size of the Board from eight to nine members
On November 14, 2024, the Board of Directors of MDU Resources Group, Inc. (the “Company”) elected Vernon A. Dosch as a director of the Board, effective November 15, 2024, to serve until the 2025 Annual Meeting of Stockholders.
Effective on the same date, Dr. Sandler resigned as a member of the Board and all committees thereof.
Hoyoung Huh, MD, PhD, James Neal and Sandip Patel resigned as directors of the Company and any committees thereof.
Hoyoung Huh, MD, PhD, James Neal and Sandip Patel resigned as directors of the Company and any committees thereof.
Hoyoung Huh, MD, PhD, James Neal and Sandip Patel resigned as directors of the Company and any committees thereof.
As previously disclosed, effective as of the Effective Time and pursuant to the terms of the Merger Agreement, the Akari Board appointed Hoyoung Huh, M.D., Ph. D, James Neal and Sandip Patel, each of whom were members of the board of directors of Peak Bio, to serve as directors for a term commencing upon the Effective Time.
Wa’el Hashad and Donald Williams resigned as directors of Akari and any committees thereof.
Wa’el Hashad and Donald Williams resigned as directors of Akari and any committees thereof.
As previously disclosed, effective as of the Effective Time and pursuant to the terms of the Merger Agreement, the Akari Board appointed Hoyoung Huh, M.D., Ph. D, James Neal and Sandip Patel, each of whom were members of the board of directors of Peak Bio, to serve as directors for a term commencing upon the Effective Time.
On November 7, 2024, in connection with the IPO, Jonathan Cole, Jody Sitkoski, and Susie Kuan (together with Gus Garcia, Lewis Silberman and Anantha Ramamurti, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On November 7, 2024, in connection with the IPO, Jonathan Cole, Jody Sitkoski, and Susie Kuan (together with Gus Garcia, Lewis Silberman and Anantha Ramamurti, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On November 7, 2024, in connection with the IPO, Jonathan Cole, Jody Sitkoski, and Susie Kuan (together with Gus Garcia, Lewis Silberman and Anantha Ramamurti, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
Harlan Weisman, M.D., Robert J. Mills, Stephen Rocamboli, Brandi Roberts, Catherine Lee and Thomas King, each notified the Company of their respective resignations as members of the Board and all committees thereof, effective November 14, 2024.
Harlan Weisman, M.D., Robert J. Mills, Stephen Rocamboli, Brandi Roberts, Catherine Lee and Thomas King, each notified the Company of their respective resignations as members of the Board and all committees thereof, effective November 14, 2024.
Harlan Weisman, M.D., Robert J. Mills, Stephen Rocamboli, Brandi Roberts, Catherine Lee and Thomas King, each notified the Company of their respective resignations as members of the Board and all committees thereof, effective November 14, 2024.
Harlan Weisman, M.D., Robert J. Mills, Stephen Rocamboli, Brandi Roberts, Catherine Lee and Thomas King, each notified the Company of their respective resignations as members of the Board and all committees thereof, effective November 14, 2024.
the Board appointed Craig R. Jalbert, age 63, as the Company's President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary and sole member of the Board, effective November 14, 2024.
Harlan Weisman, M.D., Robert J. Mills, Stephen Rocamboli, Brandi Roberts, Catherine Lee and Thomas King, each notified the Company of their respective resignations as members of the Board and all committees thereof, effective November 14, 2024.
Harlan Weisman, M.D., Robert J. Mills, Stephen Rocamboli, Brandi Roberts, Catherine Lee and Thomas King, each notified the Company of their respective resignations as members of the Board and all committees thereof, effective November 14, 2024.
On November 7, 2024, W. Andrew Adams notified National HealthCare Corporation (the “Company”) that, after 32 years of service, he intends to retire as a member of the Company Board of Directors (the “Board”) effective at the conclusion of the 2025 annual meeting of shareholders to be held on May 8, 2025.
Robert Wallace McCollar, age 61, will assume the role of Director on the Board, effective November 6, 2024.
Birge Watkins, age 75, will assume the role of Director on the Board, effective November 6, 2024.
On November 12, 2024, Robert E. Grote and Ellen F. Harshman, members of the Company’s Board of Directors (the “Board”), notified the Company of their decisions to retire as directors of the Company.
On November 12, 2024, Robert E. Grote and Ellen F. Harshman, members of the Company’s Board of Directors (the “Board”), notified the Company of their decisions to retire as directors of the Company.
On November 12, 2024, Dag Skindlo announced to the board of directors (the “Board”) of the Company his intention to resign with immediate effect.
On November 6, 2024, Rebecca Macieira-Kaufmann resigned as a member of the Board of the Company, effective November 23, 2024.
On November 6, 2024, Peter K. Scaturro resigned as a member of the Board of the Company, effective November 23, 2024.
On November 6, 2024, Elizabeth Mora resigned as a member of the Board of the Company, effective November 23, 2024.
On November 13, 2024, the Board of Directors (the “Board”) of Kimberly-Clark Corporation (the “Corporation”) elected Joseph Romanelli, 51, as an independent member of the Board
On November 13, 2024, the Board of Directors (the “Board”) of PVH Corp. (the “Company”) appointed Jesper Andersen, 54, to the Board, effective immediately.
On November 8, 2024, State Street Corporation’s Board of Directors elected Patricia Halliday as a director of the corporation.
On November 13, 2024, Jeh C. Johnson notified the Board of Directors of Lockheed Martin Corporation (the “Company”) that he was resigning from the Board of Directors, effective November 13, 2024.
On November 11, 2024 (the “ Appointment Date ”), Tolga Tanguler was appointed to the board of directors of the Company (the “ Board ”).
on November 11, 2024, Mr. Bruce resigned from the Board.
five new directors were appointed to the Board, including Michael Max Bühler, Stephen Kukucha, Jamila Piracci, Ray Quintana and Thomas G. Anderson.
five new directors were appointed to the Board, including Michael Max Bühler, Stephen Kukucha, Jamila Piracci, Ray Quintana and Thomas G. Anderson.
five new directors were appointed to the Board, including Michael Max Bühler, Stephen Kukucha, Jamila Piracci, Ray Quintana and Thomas G. Anderson.
Mr. Quintana and Mr. Anderson resigned from the Board as chairman and director and as director, respectively
five new directors were appointed to the Board, including Michael Max Bühler, Stephen Kukucha, Jamila Piracci, Ray Quintana and Thomas G. Anderson.
Mr. Quintana and Mr. Anderson resigned from the Board as chairman and director and as director, respectively
five new directors were appointed to the Board, including Michael Max Bühler, Stephen Kukucha, Jamila Piracci, Ray Quintana and Thomas G. Anderson.
On November 12, 2024, the Board appointed Garrett Lustig to the Board, effective immediately.
On November 8, 2024, in connection with entering into the Agreement, the Board increased the size of the Board to seven members and appointed Mr. Vardeman to the Board, effective November 11, 2024.
Holden Spaht, Brian Jaffee, Charles Goodman, Erik Akopiantz, James Hutter, Ossa Fisher and Lloyd Waterhouse resigned from the board of directors of the Company and any committee thereof.
Holden Spaht, Brian Jaffee, Charles Goodman, Erik Akopiantz, James Hutter, Ossa Fisher and Lloyd Waterhouse resigned from the board of directors of the Company and any committee thereof.
Holden Spaht, Brian Jaffee, Charles Goodman, Erik Akopiantz, James Hutter, Ossa Fisher and Lloyd Waterhouse resigned from the board of directors of the Company and any committee thereof.
Holden Spaht, Brian Jaffee, Charles Goodman, Erik Akopiantz, James Hutter, Ossa Fisher and Lloyd Waterhouse resigned from the board of directors of the Company and any committee thereof.
Holden Spaht, Brian Jaffee, Charles Goodman, Erik Akopiantz, James Hutter, Ossa Fisher and Lloyd Waterhouse resigned from the board of directors of the Company and any committee thereof.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.